Symbiotic, a restaking protocol designed to rival EigenLayer, has announced the successful completion of a $29 million Series A funding round. The funding, led by Pantera Capital and participated in by Coinbase Ventures and over 100 angel investors, will be utilized to expand the current team and contribute to the development of the protocol's Universal Staking framework. This expansion will enable Symbiotic to support a wider range of staking activities, including insurance and other financial products, rather than focusing solely on shared security.
By allowing any combination of assets to secure any class of network, Symbiotic aims to provide a more modular and flexible approach to staking. The protocol's ability to support use cases beyond traditional staking, such as insurance and other financial products, sets it apart from its competitors.
With this new funding, Symbiotic is poised to challenge EigenLayer's dominance in the restaking market, which has seen significant growth in recent years, with billions of dollars invested in various restaking protocols. As the restaking landscape continues to evolve, Symbiotic's innovative approach and expanded capabilities position it for success in the rapidly changing DeFi landscape.